Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.[1]
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.039.594 |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.299 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Principal action is inhibition of protein denaturation.
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).